INVESTORS & MEDIA
News Release
Regeneron to Report Second Quarter 2012 Financial and Operating Results and Host Conference Call and Webcast on July 25, 2012
Live audio of the conference call will be webcast online simultaneously. A link to the webcast may be accessed from the 'Events and Presentations' page of Regeneron's website at www.regeneron.com. A replay of the conference call and webcast will be archived on the Company's website and will be available for 30 days.
Regeneron is a fully integrated biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets two products in
Contact Information:
|
|
Investor Relations |
Corporate Communications |
914-847-5126 |
914.847.7640 |
SOURCE
News Provided by Acquire Media